US Patent 7691820 Preparation of thioarabinofuranosyl compounds and use thereof
Patent 7691820 was granted and assigned to Southern Research Institute on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+128 characters)
Article
Patent abstract
Patients suffering from cancer are treated by being administered a compound represented by the following formula:
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
John A. Montgomery0
John A. Secrist, III0
Kamal N. Tiwari0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07691820 Preparation of thioarabinofuranosyl compounds and use thereof US Patent 7691820 Preparation of thioarabinofuranosyl compounds and use thereof
Infobox
Patent Number
076918200
Patent Number
76918200
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076918200
Date of Patent
April 6, 2010
0Patent Application Number
115090300
Date Filed
August 24, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07691820 Preparation of thioarabinofuranosyl compounds and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07691820
Date of patent
April 6, 2010
Patent application number
11509030
Date Filed
August 24, 2006
Patent primary examiner
Find more entities like US Patent 7691820 Preparation of thioarabinofuranosyl compounds and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.